2014Journal of Chongqing Technology and Business UniversityRequires access

Research Progress in Xanthine Oxidase Inhibitor from Natural Products

Tan Ming-lian

Open publisher page 0 citations

Abstract

Hyperuricemia and gout are common and frequently-occuring diseases and can not be cured currently. Although frequently-used clinical hypouricemic medicine,allopurinol,has notably curing effect,its sideeffect is serious,and its application is obviously restricted. As a result,it has been a hot point to search for hypouricemic medicines with high activity and low toxicity. Xanthine Odidase is an important enzyme to catalyze the production of uric acid. This paper aims to review the research achievement for the extraction of natural products and the inhibition of Xanthine Oxidase activity by active site and monomer components.

About this research paper

What this paper is about

Hyperuricemia and gout are common and frequently-occuring diseases and can not be cured currently. Although frequently-used clinical hypouricemic medicine,allopurinol,has notably curing effect,its sideeffect is serious,and its application is obviously restricted. As a result,it has been a hot point to search for hypouricemic medicines with high activity and low toxicity. Xanthine Odidase is an important enzyme to catalyze the production of uric acid. This paper aims to review the research achievement for the extraction of natural products and the inhibition of Xanthine Oxidase activity by active site and monomer components.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Hyperuricemia and gout are common and frequently-occuring diseases and can not be cured currently. Although frequently-used clinical hypouricemic medicine,allopurinol,has notably curing effect,its sideeffect is serious,and its application is obviously restricted. As a result,it has been a hot point to search for hypouricemic medicines with high activity and low toxicity. Xanthine Odidase is an important enzyme to catalyze the production of uric acid. This paper aims to review the research achievement for the extraction of natural products and the inhibition of Xanthine Oxidase activity by active site and monomer components.

Key concepts: Xanthine oxidase, Hyperuricemia, Allopurinol, Gout, Xanthine oxidase inhibitor, Uric acid, Chemistry, Xanthine dehydrogenase

Related papers

Back to paper searchBrowse research topicsOriginal source
Research Progress in Xanthine Oxidase Inhibitor from Natural Products — Research Paper | ScholarLens